Safety of Baricitinib in Japanese Patients with Rheumatoid Arthritis (RA): The 2020 Interim Report from All-case Post Marketing Surveillance in Clinical Practice

被引：0
|
作者：
Fujii, Takao [1 ]
Atsumi, Tatsuya [2 ]
Okamoto, Nami [3 ]
Takahashi, Nobunori [4 ]
Tamura, Naoto [5 ]
Nakajima, Atsuo [6 ]
Nakajima, Ayako [7 ]
Matsuno, Hiroaki [8 ]
Tsujimoto, Naoto [9 ]
Nishikawa, Atsushi [9 ]
Ishii, Taeko [9 ]
Takeuchi, Tsutomu [10 ]
Kuwana, Masataka [11 ]
Takagi, Michiaki [12 ]
机构：
[1] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan
[2] Hokkaido Univ, Sapporo, Hokkaido, Japan
[3] Osaka Med Coll, Takatsuki, Osaka, Japan
[4] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[5] Juntendo Univ, Fac Med, Dept Internal Med & Rheumatol, Tokyo, Japan
[6] Ueno Touseki Clin, Fukuoka, Japan
[7] Mie Univ Hosp, Ctr Rheumat Dis, Tsu, Mie, Japan
[8] Matsuno Clin Rheumat Dis, Toyama, Japan
[9] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[10] Keio Univ, Div Rheumatol, Tokyo, Japan
[11] Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan
[12] Yamagata Univ, Fac Med, Dept Orthopaed Surg, Yamagata, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1676
引用
收藏
页码：3489 / 3490
页数：2
相关论文
共 50 条
  • [41] All-case post-marketing surveillance (PMS) of pirfenidone in Japan: Clinical characteristics, efficacy and safety profile in >1300 patients with idiopathic pulmonary fibrosis (IPF)
    Inoue, Yoshikazu
    Azuma, Arata
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Chida, Kingo
    Bando, Masashi
    Niimi, Yuka
    Kakutani, Shinichi
    Suga, Moritaka
    Sugiyama, Yukihiko
    Kudoh, Shoji
    Nukiwa, Toshihiro
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [42] Safety and effectiveness of Tadalafil on PAH from a post-marketing surveillance (Investigation on all patients in Japan, interim data)
    Xin, Ping
    Murakami, Masahiro
    Umeki, Yasuhiro
    Taketsuna, Masanori
    Kobayashi, Nobuyuki
    Yamazaki, Hiroyoshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C226 - C227
  • [43] Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients
    Koike, Takao
    Harigai, Masayoshi
    Ishiguro, Naoki
    Inokuma, Shigeko
    Takei, Syuji
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Haruna, Shigenori
    Ushida, Naoko
    Kawana, Katsuyoshi
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 390 - 398
  • [44] Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Burmester, Gerd R.
    Coates, Laura C.
    Cohen, Stanley B.
    Tanaka, Yoshiya
    Vranic, Ivana
    Nagy, Edward
    Lazariciu, Irina
    Chen, All-shine
    Kwok, Kenneth
    Fallon, Lara
    Kinch, Cassandra
    RHEUMATOLOGY AND THERAPY, 2023, 10 (05) : 1255 - 1276
  • [45] POST-MARKETING SAFETY SURVEILLANCE OF TOFACITINIB OVER 9 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
    Burmester, G. R.
    Coates, L.
    Cohen, S. B.
    Tanaka, Y.
    Vranic, I.
    Nagy, E.
    Chen, A. S.
    Lazariciu, I.
    Kwok, K.
    Fallon, L.
    Kinch, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 347 - 348
  • [46] Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Gerd R. Burmester
    Laura C. Coates
    Stanley B. Cohen
    Yoshiya Tanaka
    Ivana Vranic
    Edward Nagy
    Irina Lazariciu
    All-shine Chen
    Kenneth Kwok
    Lara Fallon
    Cassandra Kinch
    Rheumatology and Therapy, 2023, 10 : 1255 - 1276
  • [47] Tuberculosis and serious infusion reactions in Japanese patients with rheumatoid arthritis: Results from the post marketing surveillance trial.
    Dabbous, Omar
    Tatsuki, Yoshihiko
    Rahman, Mirza I.
    Gilmer, Keith
    Arjunji, Ramesh
    Thompson, Heidi
    Togo, Masanori
    Tang, Boxiong
    Suzuki, Toshikazu
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S422 - S422
  • [48] Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
    Kimata, Masahiro
    Watanabe, Asuka
    Yanagida, Yukiko
    Kinoshita, Daisuke
    Maekawa, Shinichiroh
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (04) : 1119 - 1136
  • [49] Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
    Masahiro Kimata
    Asuka Watanabe
    Yukiko Yanagida
    Daisuke Kinoshita
    Shinichiroh Maekawa
    Infectious Diseases and Therapy, 2023, 12 : 1119 - 1136
  • [50] Post-marketing surveillance of all patients treated with sorafenib for unresectable DTC in Japan: Interim report
    Tahara, Makoto
    Sugitani, Iwao
    Ito, Yasuhiro
    Okayama, Yutaka
    Kawakami, Yoshiko
    Sunaya, Toshiyuki
    Sakaguchi, Toshiaki
    Minami, Hironobu
    Imai, Tsuneo
    ANNALS OF ONCOLOGY, 2016, 27
12345